Skip to main content

Zynerba Pharmaceuticals, Inc.

ZYNEDelisted Oct 11, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001621443

Zynerba Pharmaceuticals, Inc. was delisted on Oct 11, 2023; its insiders filed their last Form 4 on Oct 11, 2023; 43 institutions reported holding it in 13F filings for Q3 2023, worth $14.7M in total; no superinvestor held it.

13F holders, Q4 2023

Institutional positions in Zynerba Pharmaceuticals, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

ZYNE is no longer listed, and 13F filings after Q3 2023 list far fewer holders. See Q3 2023

Institutional holders
0
−43 vs. Q3 2023
Shares held
0
−11.5M (−100.0%) vs. Q3 2023
Total value
$0
−$14.7M (−100.0%) vs. Q3 2023
New holders
0
0 more added
Sold out
43
0 more reduced

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ZYNE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 0 institutions
Q1 2021: 67 institutionsQ2 2021: 65 institutionsQ3 2021: 59 institutionsQ4 2021: 62 institutionsQ1 2022: 59 institutionsQ2 2022: 56 institutionsQ3 2022: 62 institutionsQ4 2022: 50 institutionsQ1 2023: 44 institutionsQ2 2023: 41 institutionsQ3 2023: 43 institutionsQ4 2023: 0 institutionsQ1 2024: 1 institutionQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2023: $0
Q1 2021: $42.1MQ2 2021: $78.1MQ3 2021: $57.1MQ4 2021: $38.3MQ1 2022: $24.8MQ2 2022: $12.5MQ3 2022: $7.97MQ4 2022: $4.23MQ1 2023: $2.75MQ2 2023: $1.74MQ3 2023: $14.7MQ4 2023: $0Q1 2024: $16.2KQ2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ZYNE and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20241$16.2K
Q4 20230$0
Q3 202343$14.7M
Q2 202341$1.74M
Q1 202344$2.75M
Q4 202250$4.23M
Q3 202262$7.97M
Q2 202256$12.5M
Q1 202259$24.8M
Q4 202162$38.3M
Q3 202159$57.1M
Q2 202165$78.1M
Q1 202167$42.1M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Zynerba Pharmaceuticals, Inc.; share changes are against Q3 2023.

Institutions holding ZYNE in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Beryl Capital Management LLC0$00.00%−4,898,927−100.0%Sold out
Highbridge Capital Management LLC0$00.00%−2,283,979−100.0%Sold out
Yakira Capital Management, Inc.0$00.00%−620,019−100.0%Sold out
Renaissance Technologies LLC0$00.00%−605,700−100.0%Sold out
CSS LLC0$00.00%−476,831−100.0%Sold out
Deltec Asset Management LLC0$00.00%−475,000−100.0%Sold out
Millennium Management LLC0$00.00%−325,237−100.0%Sold out
Jane Street Group, LLC0$00.00%−282,478−100.0%Sold out
Crystalline Management Inc.0$00.00%−230,817−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−221,719−100.0%Sold out
Penserra Capital Management LLC0$00.00%−220,858−100.0%Sold out
HRT Financial LP0$00.00%−203,229−100.0%Sold out
PenderFund Capital Management Ltd.0$00.00%−123,444−100.0%Sold out
GTS Securities LLC0$00.00%−120,121−100.0%Sold out
Fifth Lane Capital, LP0$00.00%−100,000−100.0%Sold out
Northern Trust Corp0$00.00%−46,072−100.0%Sold out
Geode Capital Management, LLC0$00.00%−37,934−100.0%Sold out
Charles Schwab Investment Management Inc0$00.00%−37,596−100.0%Sold out
Morgan Stanley0$00.00%−34,783−100.0%Sold out
Cetera Advisor Networks LLC0$00.00%−22,124−100.0%Sold out
JPMorgan Chase & Co0$00.00%−20,875−100.0%Sold out
UBS Group AG0$00.00%−20,385−100.0%Sold out
XTX Topco Ltd0$00.00%−18,793−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−16,161−100.0%Sold out
King Wealth0$00.00%−16,000−100.0%Sold out
Virtu Financial LLC0$00.00%−13,098−100.0%Sold out
National Asset Management, Inc.0$00.00%−12,732−100.0%Sold out
Key Financial Inc0$00.00%−7,500−100.0%Sold out
Newbridge Financial Services Group, Inc.0$00.00%−3,610−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−2,814−100.0%Sold out
Wells Fargo & Company0$00.00%−2,464−100.0%Sold out
Founders Capital Management0$00.00%−2,000−100.0%Sold out
Rhumbline Advisers0$00.00%−805−100.0%Sold out
Sound Income Strategies, LLC0$00.00%−350−100.0%Sold out
Bank of America Corp0$00.00%−282−100.0%Sold out
Harbour Investments, Inc.0$00.00%−100−100.0%Sold out
Creative Planning0$00.00%−100−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−100−100.0%Sold out
HM Payson & Co0$00.00%−50−100.0%Sold out
GHP Investment Advisors, Inc.0$00.00%−1−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−1−100.0%Sold out
Iron Horse Wealth Management, LLC0$00.00%−1−100.0%Sold out
Royal Bank of Canada0$00.00%−315−100.0%Sold out